Aurobindo Pharma Total Debt vs. Return On Equity
| AUROPHARMA | 1,263 18.60 1.50% |
For Aurobindo Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Aurobindo Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Aurobindo Pharma Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Aurobindo Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Aurobindo Pharma Limited over time as well as its relative position and ranking within its peers.
Aurobindo |
Aurobindo Pharma Return On Equity vs. Total Debt Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Aurobindo Pharma's current stock value. Our valuation model uses many indicators to compare Aurobindo Pharma value to that of its competitors to determine the firm's financial worth. Aurobindo Pharma Limited is the top company in total debt category among its peers. It also is number one stock in return on equity category among its peers . The ratio of Total Debt to Return On Equity for Aurobindo Pharma Limited is about 548,032,151,690 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Aurobindo Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Aurobindo Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Aurobindo Total Debt vs. Competition
Aurobindo Pharma Limited is the top company in total debt category among its peers. Total debt of Health Care industry is presently estimated at about 316.52 Billion. Aurobindo Pharma totals roughly 66.48 Billion in total debt claiming about 21% of equities under Health Care industry.
Aurobindo Return On Equity vs. Total Debt
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Aurobindo Pharma |
| = | 66.48 B |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Aurobindo Pharma |
| = | 0.12 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Aurobindo Return On Equity Comparison
Aurobindo Pharma is currently under evaluation in return on equity category among its peers.
Aurobindo Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Aurobindo Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Aurobindo Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Aurobindo Pharma's change in net profit over the period of time. It can combine multiple indicators of Aurobindo Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 25.6 B | 26.9 B | |
| Operating Income | 104.5 B | 109.7 B | |
| Income Before Tax | 43.8 B | 46 B | |
| Total Other Income Expense Net | -60.7 B | -57.7 B | |
| Net Income | 31.7 B | 20.3 B | |
| Income Tax Expense | 12.1 B | 12.7 B | |
| Net Income From Continuing Ops | 31.7 B | 27.8 B | |
| Net Income Applicable To Common Shares | 22.2 B | 27.1 B | |
| Interest Income | 2.9 B | 3 B | |
| Net Interest Income | -2.9 B | -2.8 B | |
| Change To Netincome | 2.8 B | 2.9 B |
Aurobindo Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Aurobindo Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Aurobindo Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Aurobindo Pharma's important profitability drivers and their relationship over time.
Use Aurobindo Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Aurobindo Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aurobindo Pharma will appreciate offsetting losses from the drop in the long position's value.Aurobindo Pharma Pair Trading
Aurobindo Pharma Limited Pair Trading Analysis
The ability to find closely correlated positions to Aurobindo Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Aurobindo Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Aurobindo Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Aurobindo Pharma Limited to buy it.
The correlation of Aurobindo Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Aurobindo Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Aurobindo Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Aurobindo Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Aurobindo Pharma position
In addition to having Aurobindo Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Tech Funds Thematic Idea Now
Tech Funds
Funds or Etfs that invest in companies involved in research, development, testing, or distribution of technologically based goods and services. The Tech Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Tech Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Aurobindo Stock
To fully project Aurobindo Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Aurobindo Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Aurobindo Pharma's income statement, its balance sheet, and the statement of cash flows.